Archive

Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

03 marzo, 2021

African Swine Fever Virus Ubiquitin-Conjugating Enzyme Interacts With Host Translation Machinery to Regulate the Host Protein Synthesis 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

03 marzo, 2021

“Illegal vaccines endanger the eradication of African swine fever in Asia”

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

03 marzo, 2021

Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

02 marzo, 2021

Editorial: African Swine Fever 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

27 enero, 2021

«African Swine Fever is worse than ever»

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

14 enero, 2021

Distinct African Swine Fever Virus Shedding in Wild Boar Infected with Virulent and Attenuated Isolates 🇬🇧

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

12 diciembre, 2020

VACDIVA FIRST ANNUAL NEWSLETTER

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

02 diciembre, 2020

VACDIVA FULL CONSORTIUM AND GENERAL ASSEMBLY 2020

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

26 noviembre, 2020

VACDIVA joins FAO and OIE kickstart global initiative to stop spread of ASF

The VACDIVA Project, which will last the following four years, aims to develop an effective vaccine against African Swine Fever (ASF). The vaccine would solve the current problem in Europe...

26 noviembre, 2020